Clinical Study
Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
Table 1
Demographic, etiological, and virological features of the 50 cases with a successful response before OLT.
| | Age (y) | 50.82 ± 8.58 (52.00, 27–69) | | Gender (M/F) | 41/9 | | Postoperative time (months) | 35.80 ± 19.12 (27.00, 12.00–85.00) | | Diagnosis | | | Liver failure (, %) | 12, 24% | | Liver cirrhosis (, %) | 22, 44% | | HCC (, %) | 4, 8% | | Liver cirrhosis and HCC (, %) | 12, 24% | | HBsAg (+)/(−) | 50/0 | Sera HBV DNA preoperation
≥103/<103 copies/mL | 19/31 |
|
|
